- Record: found
- Abstract: not found
- Article: not found
Long-term safety and efficacy of axicabtagene ciloleucel (anti-CD19 CAR T) in refractory large B-cell lymphoma: a multicenter, single arm, phase 1–2 trial
FL Locke, A Ghobadi, CA Jacobson, DB Miklos, LJ Lekakis, OO Oluwole, Y LIN, I. Braunschweig, BT Hill, JM Timmerman, A Deol
2018
Read this article at
ScienceOpen
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.